CMAJ| FEBRUARY 21, 2017| VOLUME 189| ISSUE 7 E259 required in 10%–20% of the
patients. 9–11 Only one study12 examined a large cohort of patients with de novo acute …

BACKGROUND: Conflicting recommendations exist on whether high-flow nasal cannula
(HFNC) oxygen therapy should be administered to adult patients in critical care with acute …

PURPOSE: In adults with acute hypoxemic respiratory failure (AHRF), most high flow nasal
cannula (HFNC) studies evaluated patient comfort and physiologic parameters such as …

Background This systematic review and meta-analysis summarizes the safety and efficacy of
high flow nasal cannula (HFNC) in patients with acute hypoxemic respiratory failure …

INTRODUCTION: High flow nasal cannula oxygen (HFNCO) is being increasingly utilized in
patients with acute respiratory failure. Current research shows HFNCO improves outcomes …

Background We performed a systematic review and meta-analysis to evaluate the efficacy
and safety of high-flow oxygen via nasal cannulae (HFNC) compared to non-invasive …

Introduction To evaluate the efficacy of high-flow nasal cannula (HFNC) in the rate of
intubation and mortality for patients with acute hypoxemic respiratory failure. Methods We …

BACKGROUND: We evaluated the efficacy of high-flow nasal cannula (HFNC) therapy, a
promising respiratory support method for acute hypoxemic respiratory failure (AHRF) …

Introduction High flow nasal cannula (HFNC) is a noninvasive ventilation (NIV) system that
has demonstrated promise in the emergency department (ED) setting. Objective This …

Since the first description of a case series of adult patients with acute respiratory failure
(ARF) treated with high-flow nasal cannula (HFNC)(1), evidence regarding the use of this …